AAPL297.11+2.81 (+0.95%) ▲|ABBV233.23-1.53 (-0.65%) ▼|ABT91.02+0.49 (+0.54%) ▲|ACN128.32+1.31 (+1.03%) ▲|ADBE200.14+2.71 (+1.37%) ▲|AMAT587.97+2.09 (+0.36%) ▲|AMD518.31-1.54 (-0.30%) ▼|AMGN351.38+4.37 (+1.26%) ▲|AMT174.81-4.57 (-2.55%) ▼|AMZN241.29+7.18 (+3.07%) ▲|AVGO385.58+5.43 (+1.43%) ▲|AXP342.40+4.62 (+1.37%) ▲|BA221.13+4.42 (+2.04%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG183.47+14.53 (+8.60%) ▲|BLK984.16-31.17 (-3.07%) ▼|BMY55.29-0.25 (-0.44%) ▼|BNY145.71-1.58 (-1.07%) ▼|BRK-B496.34+3.53 (+0.72%) ▲|C144.26-0.71 (-0.49%) ▼|CAT1,000.22+15.98 (+1.62%) ▲|CL92.42+0.99 (+1.08%) ▲|CMCSA22.72-0.08 (-0.35%) ▼|COF202.07+4.26 (+2.15%) ▲|COP106.34-3.63 (-3.30%) ▼|COST962.15+4.47 (+0.47%) ▲|CRM155.16+1.74 (+1.13%) ▲|CSCO122.07+0.92 (+0.76%) ▲|CVS100.14-1.43 (-1.41%) ▼|CVX170.95-5.03 (-2.86%) ▼|DE607.33+15.39 (+2.60%) ▲|DHR188.00+9.03 (+5.05%) ▲|DIS103.90+0.37 (+0.36%) ▲|DUK125.22+0.17 (+0.14%) ▲|EMR143.84+0.70 (+0.49%) ▲|FDX312.67-4.57 (-1.44%) ▼|GD345.92-4.43 (-1.26%) ▼|GE367.75+11.28 (+3.16%) ▲|GEV1,061.97+26.99 (+2.61%) ▲|GILD125.53+0.48 (+0.38%) ▲|GM79.72+0.77 (+0.98%) ▲|GOOG351.73+5.65 (+1.63%) ▲|GOOGL352.40+6.31 (+1.82%) ▲|GS1,081.71-12.73 (-1.16%) ▼|HD338.99+14.54 (+4.48%) ▲|HON228.52+6.15 (+2.76%) ▲|IBM263.03-1.91 (-0.72%) ▼|INTC135.30+3.02 (+2.28%) ▲|INTU266.49+8.44 (+3.27%) ▲|ISRG404.56+1.38 (+0.34%) ▲|JNJ239.90+0.82 (+0.34%) ▲|JPM332.88-1.27 (-0.38%) ▼|KO81.26+0.95 (+1.18%) ▲|LIN520.77+8.51 (+1.66%) ▲|LLY1,106.33-0.76 (-0.07%) ▼|LMT496.16-7.51 (-1.49%) ▼|LOW221.27+7.73 (+3.62%) ▲|LRCX370.22-1.11 (-0.30%) ▼|MA496.11+8.04 (+1.65%) ▲|MCD273.96+2.30 (+0.85%) ▲|MDLZ62.20+1.14 (+1.87%) ▲|MDT80.73+0.10 (+0.12%) ▲|META565.67+3.47 (+0.62%) ▲|MMM167.96+6.12 (+3.78%) ▲|MO71.51-0.10 (-0.14%) ▼|MRK119.57-0.03 (-0.03%) ▼|MS222.58-3.45 (-1.53%) ▼|MSFT374.78+0.84 (+0.22%) ▲|MU1,044.62-7.15 (-0.68%) ▼|NEE86.61+0.18 (+0.21%) ▲|NFLX72.42-0.40 (-0.55%) ▼|NKE41.88-0.51 (-1.19%) ▼|NOW95.66-0.28 (-0.29%) ▼|NVDA201.15+1.15 (+0.58%) ▲|ORCL160.23-4.93 (-2.99%) ▼|PEP143.07+1.02 (+0.72%) ▲|PFE24.34-0.38 (-1.52%) ▼|PG152.76+1.90 (+1.26%) ▲|PLTR115.34-1.37 (-1.17%) ▼|PM177.59-1.10 (-0.62%) ▼|QCOM199.00-5.13 (-2.51%) ▼|RTX185.80-0.59 (-0.32%) ▼|SBUX103.14+2.09 (+2.07%) ▲|SCHW91.77-1.41 (-1.51%) ▼|SO94.79-0.14 (-0.15%) ▼|SPG218.26+1.52 (+0.70%) ▲|T22.52-0.30 (-1.29%) ▼|TMO487.55+18.20 (+3.88%) ▲|TMUS183.52-1.05 (-0.57%) ▼|TSLA382.92+1.31 (+0.34%) ▲|TXN305.33+0.97 (+0.32%) ▲|UBER74.72+5.05 (+7.25%) ▲|UNH403.79-5.47 (-1.34%) ▼|UNP262.44+3.83 (+1.48%) ▲|UPS105.65-0.18 (-0.17%) ▼|USB60.10+0.05 (+0.08%) ▲|V332.54+4.06 (+1.23%) ▲|VZ45.84-0.90 (-1.92%) ▼|WFC83.96-0.17 (-0.20%) ▼|WMT119.78+0.36 (+0.30%) ▲|XOM135.81-3.92 (-2.81%) ▼|AAPL297.11+2.81 (+0.95%) ▲|ABBV233.23-1.53 (-0.65%) ▼|ABT91.02+0.49 (+0.54%) ▲|ACN128.32+1.31 (+1.03%) ▲|ADBE200.14+2.71 (+1.37%) ▲|AMAT587.97+2.09 (+0.36%) ▲|AMD518.31-1.54 (-0.30%) ▼|AMGN351.38+4.37 (+1.26%) ▲|AMT174.81-4.57 (-2.55%) ▼|AMZN241.29+7.18 (+3.07%) ▲|AVGO385.58+5.43 (+1.43%) ▲|AXP342.40+4.62 (+1.37%) ▲|BA221.13+4.42 (+2.04%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG183.47+14.53 (+8.60%) ▲|BLK984.16-31.17 (-3.07%) ▼|BMY55.29-0.25 (-0.44%) ▼|BNY145.71-1.58 (-1.07%) ▼|BRK-B496.34+3.53 (+0.72%) ▲|C144.26-0.71 (-0.49%) ▼|CAT1,000.22+15.98 (+1.62%) ▲|CL92.42+0.99 (+1.08%) ▲|CMCSA22.72-0.08 (-0.35%) ▼|COF202.07+4.26 (+2.15%) ▲|COP106.34-3.63 (-3.30%) ▼|COST962.15+4.47 (+0.47%) ▲|CRM155.16+1.74 (+1.13%) ▲|CSCO122.07+0.92 (+0.76%) ▲|CVS100.14-1.43 (-1.41%) ▼|CVX170.95-5.03 (-2.86%) ▼|DE607.33+15.39 (+2.60%) ▲|DHR188.00+9.03 (+5.05%) ▲|DIS103.90+0.37 (+0.36%) ▲|DUK125.22+0.17 (+0.14%) ▲|EMR143.84+0.70 (+0.49%) ▲|FDX312.67-4.57 (-1.44%) ▼|GD345.92-4.43 (-1.26%) ▼|GE367.75+11.28 (+3.16%) ▲|GEV1,061.97+26.99 (+2.61%) ▲|GILD125.53+0.48 (+0.38%) ▲|GM79.72+0.77 (+0.98%) ▲|GOOG351.73+5.65 (+1.63%) ▲|GOOGL352.40+6.31 (+1.82%) ▲|GS1,081.71-12.73 (-1.16%) ▼|HD338.99+14.54 (+4.48%) ▲|HON228.52+6.15 (+2.76%) ▲|IBM263.03-1.91 (-0.72%) ▼|INTC135.30+3.02 (+2.28%) ▲|INTU266.49+8.44 (+3.27%) ▲|ISRG404.56+1.38 (+0.34%) ▲|JNJ239.90+0.82 (+0.34%) ▲|JPM332.88-1.27 (-0.38%) ▼|KO81.26+0.95 (+1.18%) ▲|LIN520.77+8.51 (+1.66%) ▲|LLY1,106.33-0.76 (-0.07%) ▼|LMT496.16-7.51 (-1.49%) ▼|LOW221.27+7.73 (+3.62%) ▲|LRCX370.22-1.11 (-0.30%) ▼|MA496.11+8.04 (+1.65%) ▲|MCD273.96+2.30 (+0.85%) ▲|MDLZ62.20+1.14 (+1.87%) ▲|MDT80.73+0.10 (+0.12%) ▲|META565.67+3.47 (+0.62%) ▲|MMM167.96+6.12 (+3.78%) ▲|MO71.51-0.10 (-0.14%) ▼|MRK119.57-0.03 (-0.03%) ▼|MS222.58-3.45 (-1.53%) ▼|MSFT374.78+0.84 (+0.22%) ▲|MU1,044.62-7.15 (-0.68%) ▼|NEE86.61+0.18 (+0.21%) ▲|NFLX72.42-0.40 (-0.55%) ▼|NKE41.88-0.51 (-1.19%) ▼|NOW95.66-0.28 (-0.29%) ▼|NVDA201.15+1.15 (+0.58%) ▲|ORCL160.23-4.93 (-2.99%) ▼|PEP143.07+1.02 (+0.72%) ▲|PFE24.34-0.38 (-1.52%) ▼|PG152.76+1.90 (+1.26%) ▲|PLTR115.34-1.37 (-1.17%) ▼|PM177.59-1.10 (-0.62%) ▼|QCOM199.00-5.13 (-2.51%) ▼|RTX185.80-0.59 (-0.32%) ▼|SBUX103.14+2.09 (+2.07%) ▲|SCHW91.77-1.41 (-1.51%) ▼|SO94.79-0.14 (-0.15%) ▼|SPG218.26+1.52 (+0.70%) ▲|T22.52-0.30 (-1.29%) ▼|TMO487.55+18.20 (+3.88%) ▲|TMUS183.52-1.05 (-0.57%) ▼|TSLA382.92+1.31 (+0.34%) ▲|TXN305.33+0.97 (+0.32%) ▲|UBER74.72+5.05 (+7.25%) ▲|UNH403.79-5.47 (-1.34%) ▼|UNP262.44+3.83 (+1.48%) ▲|UPS105.65-0.18 (-0.17%) ▼|USB60.10+0.05 (+0.08%) ▲|V332.54+4.06 (+1.23%) ▲|VZ45.84-0.90 (-1.92%) ▼|WFC83.96-0.17 (-0.20%) ▼|WMT119.78+0.36 (+0.30%) ▲|XOM135.81-3.92 (-2.81%) ▼|
24.7 C
New York
Wednesday, June 24, 2026

Tag: press release

newssourceFORcompanyinformationcontent1marketreleases

MemeToro Price Prediction: $1 Talk Returns as Presale Buyers Bet on MemeToro AI Agent Solutions

ZURICH, June 07, 2026 (GLOBE NEWSWIRE) -- The cryptocurrency market is witnessing a massive convergence of artificial intelligence and digital culture. Investors are shifting capital toward functional crypto ecosystems. Memecoins have evolved far beyond basic internet jokes.

PUDO Inc announces earnings call for FY 2026 year end results

TORONTO, June 3, 2026 /CNW/ - PUDO Inc. ("PUDO" or the "Company") (CSE: PDO) (OTCQB: PDPTF), today announced that it will report its year...

Bittam Launches No-KYC Crypto Perpetual Futures Trading with 200x Leverage and ＄100 Deposit Bonus

 NEW YORK, June 06, 2026 (GLOBE NEWSWIRE) -- Bittam Exchange today announced the launch of a $300 New User Bonus for newly registered users, offering trading credits to eligible participants who complete account registration and initial trading activities on the platform.

Lilly’s triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity...

In TRIUMPH-1, participants on retatrutide 12 mg lost an average of 70.3 lbs (28.3%) over 80 weeks, with 65.3% achieving a BMI below 30,...

Are AI Crypto Trading Bots Suitable for Crypto Beginners? BulkQuant Launches an Automated Crypto Trading App

BulkQuant introduces an automated crypto trading app designed to help beginners access AI crypto trading bots with a simpler workflow, reduced manual operation, and clearer automation features. 
BulkQuant introduces an automated crypto trading app designed to help beginners access AI crypto trading bots with a simpler workflow, reduced manual operation, and clearer automation features.

All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration

NEW YORK, June 06, 2026 (GLOBE NEWSWIRE) -- All In FutureTech Alliance (Nasdaq: AIFA) (“AIFA” or the “Company”) today provided a strategic update. Following the Company’s previously announced signing of agreements to acquire a controlling interest in HyalRoute Communication Group (“HyalRoute”) and advancement of the Hainan AIFA Silicon Photonics Supercomputing Center project, the Company is further accelerating project planning, policy coordination, financing arrangements, and cross-border resource integration around its dual-engine strategy of an “AI infrastructure network powered by optical technologies” and an “AI application services matrix.”

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following a single target dose of CLN-978 

InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering

New York, NY, June 05, 2026 (GLOBE NEWSWIRE) -- InterPrivate Investment Partners V, Inc. (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, announced the closing of its initial public offering of 20,125,000 units, including 2,625,000 units issued pursuant to the exercise of the underwriters’ over-allotment option in full, at a price of $10.00 per unit on June 5, 2026. Total gross proceeds from the offering were $201.25 million before deducting underwriting discounts and commissions and other offering expenses payable by the Company.

Re: TriWest IV’s Holdings in Source Energy Services Ltd.

CALGARY, AB, June 5, 2026 /CNW/ - TriWest Capital Partners IV (US), L.P., SES Sand Holdings (Canada) LP, SES Sand Holdings 2 (Canada) LP...

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors it Has Filed a Complaint to Recover Losses Suffered by Purchasers of Verra Mobility Corporation Common...

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

DentaQuest Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information

Edelson Lechtzin LLP is investigating data privacy claims arising from the DentaQuest data breach.

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with...

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and AID Use

Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate

AMB-702 demonstrates superior target coverage and efficacy in lean non-human primates The dataset was shared as part of a poster presentation at the American Diabetes...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPress release

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers